MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Annals of Hematology

• Publication date

  2015-04-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00277-015-2369-0PMID 25900787
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In press 1

  2016cited by this paper
• Epigenetic control of autoimmune diseases: from bench to bedside.

  2015cited by this paper
• Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients

  2015cited by this paper
• MicroRNAs as master regulators of immune responses in transplant recipients

  2015cited by this paper
• High expression levels of microRNA-629, microRNA-525-5p and microRNA-516a-3p in paediatric systemic lupus erythematosus

  2014cited by this paper
• MicroRNAs in lupus

  2014cited by this paper
• Mikro-RNA: Rolle bei der Immunregulation nach allogener hämatopoetischer Stammzelltransplantation

  2014cited by this paper
• Cytogenetics in benzene‐associated myelodysplastic syndromes and acute myeloid leukemia: new insights into a disease continuum

  2014cited by this paper
• FOXP3 is a direct target of miR15a/16 in umbilical cord blood regulatory T cells

  2014cited by this paper
• Serum microRNA155 is increased in patients with acute graft‐versus‐host disease

  2014cited by this paper
• MicroRNA-21 stimulates gastric cancer growth and invasion by inhibiting the tumor suppressor effects of programmed cell death protein 4 and phosphatase and tensin homolog.

  2014cited by this paper
• MicroRNA Regulation in Systemic Lupus Erythematosus Pathogenesis

  2014cited by this paper
• [The role of microRNAs for immunoregulation after allogeneic hematopoietic cell transplantation].

  2014cited by this paper
• Therapeutic targeting of microRNAs: current status and future challenges

  2014cited by this paper
• Human bile contains MicroRNA‐laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis

  2014cited by this paper
• MiR-146a regulates the TRAF6/TNF-axis in donor T cells during GVHD.

  2014cited by this paper
• Allogeneic hematopoietic cell transplant for acute myeloid leukemia: Current state in 2013 and future directions.

  2014cited by this paper
• MicroRNA-146a: A Dominant, Negative Regulator of the Innate Immune Response

  2014cited by this paper
• Dynamic expression of microRNAs in M2b polarized macrophages associated with systemic lupus erythematosus.

  2014cited by this paper
• Consensus on the histopathological evaluation of liver biopsies from patients following allogeneic hematopoietic cell transplantation

  2014cited by this paper
• Childhood B-acute lymphoblastic leukemia: a genetic update

  2014cited by this paper
• Predicting relapse risk in childhood acute lymphoblastic leukaemia

  2013cited by this paper
• Assessing response of therapy for acute and chronic graft-versus-host disease

  2013cited by this paper
• Graft-versus-host disease biomarkers: omics and personalized medicine

  2013cited by this paper
• miRNA Profiling Discriminates Types of Rejection and Injury in Human Renal Allografts

  2013cited by this paper
• ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.

  2013cited by this paper
• Liver abnormalities in the immunosuppressed.

  2013cited by this paper
• MicroRNAs implicated in dysregulation of gene expression following human lung transplantation

  2013cited by this paper
• MicroRNA Expressions in PMBCs, CD4+, and CD8+ T-Cells from Patients Suffering from Autoimmune Addison’s Disease

  2013cited by this paper
• Inflammatory neovascularization during graft-versus-host disease is regulated by αv integrin and miR-100.

  2013cited by this paper
• Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease.

  2013cited by this paper
• Concise Review: Acute Graft‐Versus‐Host Disease: Immunobiology, Prevention, and Treatment

  2013cited by this paper
• Graft‐versus‐host disease of the skin and adjacent mucous membranes

  2013cited by this paper
• Advances in the treatment of acute graft-versus-host disease

  2013cited by this paper
• Proteomic peptide profiling for preemptive diagnosis of acute graft-versus-host disease after allogeneic stem cell transplantation

  2013cited by this paper
• Unresolved issues in hematopoietic stem cell transplantation for severe combined immunodeficiency: need for safer conditioning and reduced late effects.

  2013cited by this paper
• Increased apoptosis is linked to severe acute GVHD in patients with Fanconi anemia

  2013cited by this paper
• Inflammatory Markers in Patients after Hematopoietic Stem Cell Transplantation

  2013cited by this paper
• Proteomic analysis of exosome-like vesicles derived from breast cancer cells.

  2012cited by this paper
• MicroRNA-21 inhibits Serpini1, a gene with novel tumour suppressive effects in gastric cancer.

  2012cited by this paper
• Plasma biomarkers of lower gastrointestinal and liver acute GVHD.

  2012cited by this paper
• Plasma level of lipopolysaccharide-binding protein is indicative of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation

  2012cited by this paper
• Extracellular vesicles – vehicles that spread cancer genes

  2012cited by this paper
• Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study.

  2012cited by this paper
• Evolution of microRNA diversity and regulation in animals

  2011cited by this paper
• Discovery and validation of graft-versus-host disease biomarkers.

  2011cited by this paper
• Characterization of extracellular circulating microRNA

  2011cited by this paper
• Decreased serum albumin as a biomarker for severe acute graft-versus-host disease after reduced-intensity allogeneic hematopoietic cell transplantation.

  2011cited by this paper
• Circulating tumor cells as a window on metastasis biology in lung cancer.

  2011cited by this paper
• Stem cell self-renewal: lessons from bone marrow, gut and iPS toward clinical applications

  2011cited by this paper
• Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease.

  2011cited by this paper
• Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma

  2011cited by this paper
• Reduced mortality after allogeneic hematopoietic-cell transplantation.

  2010cited by this paper
• Mammalian microRNAs predominantly act to decrease target mRNA levels

  2010cited by this paper
• Isolation of bovine milk-derived microvesicles carrying mRNAs and microRNAs.

  2010cited by this paper
• MicroRNAs and metastasis: little RNAs go a long way.

  2010cited by this paper
• Regulation of acute graft-versus-host disease by microRNA-155.

  2010influential reference
• Functional delivery of viral miRNAs via exosomes

  2010cited by this paper
• MiRNA-451 plays a role as tumor suppressor in human glioma cells.

  2010cited by this paper
• Allogeneic hematopoietic cell transplantation: the state of the art

  2010cited by this paper
• Many faces of graft‐versus‐host disease

  2010cited by this paper
• Checks and balances: E2F—microRNA crosstalk in cancer control

  2010cited by this paper
• Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine

  2010cited by this paper
• Epigenetic targets in human neoplasms.

  2010cited by this paper
• New tricks for animal microRNAS: targeting of amino acid coding regions at conserved and nonconserved sites.

  2009cited by this paper
• Characterization of B‐ and T‐lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles

  2009cited by this paper
• MicroRNAs: Target Recognition and Regulatory Functions

  2009cited by this paper
• MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis

  2009cited by this paper
• Highlights of a new type of intercellular communication: microvesicle-based information transfer

  2009cited by this paper
• Membrane vesicles as conveyors of immune responses

  2009cited by this paper
• MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations

  2009cited by this paper
• Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model.

  2009cited by this paper
• Origins and Mechanisms of miRNAs and siRNAs.

  2009cited by this paper
• Clinical significance of the most common chromosome translocations in adult acute myeloid leukemia.

  2008cited by this paper
• Distinct microRNA expression profiles in acute myeloid leukemia with common translocations

  2008cited by this paper
• Most mammalian mRNAs are conserved targets of microRNAs.

  2008cited by this paper
• Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis.

  2008cited by this paper
• Down-Regulation of hsa-miR-10a in Chronic Myeloid Leukemia CD34+ Cells Increases USF2-Mediated Cell Growth

  2008cited by this paper
• MicroRNA expression in cytogenetically normal acute myeloid leukemia.

  2008cited by this paper
• Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression.

  2008cited by this paper
• Epigenetics in cancer.

  2008cited by this paper
• Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression.

  2008cited by this paper
• Detection of microRNA Expression in Human Peripheral Blood Microvesicles

  2008cited by this paper
• MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia.

  2008cited by this paper
• MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia.

  2008cited by this paper
• Oncogenes and cancer.

  2008cited by this paper
• MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer.

  2008cited by this paper
• Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors.

  2007cited by this paper
• Processing of intronic microRNAs

  2007cited by this paper
• MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia

  2007cited by this paper
• Argonaute proteins: mediators of RNA silencing.

  2007cited by this paper
• Investigation of microRNA alterations in leukemias and lymphomas.

  2007cited by this paper
• miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia

  2007cited by this paper
• miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia.

  2007cited by this paper
• Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

  2007cited by this paper
• RNA polymerase III transcribes human microRNAs

  2006cited by this paper
• A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes

  2006cited by this paper
• Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.

  2006cited by this paper
• Zebrafish MiR-430 Promotes Deadenylation and Clearance of Maternal mRNAs

  2006cited by this paper
• MicroRNA signatures in human cancers

  2006cited by this paper

• Unlocking protein-based biomarker potential for graft-versus-host disease following allogenic hematopoietic stem cell transplants

  2024cites this paper
• Circulating microRNAs as the achilles forte of diagnostics and prognostics in acute graft versus host disease following allogeneic hematopoietic stem cell transplantation

  2024cites this paper
• Single nucleotide polymorphisms within HLA region are associated with the outcomes of unrelated cord blood transplantation

  2021cites this paper
• Development of acoustically isolated extracellular plasma vesicles for biomarker discovery in allogeneic hematopoietic stem cell transplantation

  2021cites this paper
• Comparative Analyses of the Conformational Dynamics Between the Soluble and Membrane-Bound Cytokine Receptors

  2020cites this paper
• Biomarkers for acute and chronic graft versus host disease: state of the art

  2020cites this paper
• Periodontal disease might be a risk factor for graft versus host disease. A systematic review.

  2020cites this paper
• Aberrant Expression of the miR-181b/miR-222 after Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia

  2019cites this paper
• MicroRNAs and Transplantation.

  2019cites this paper
• Clinical Approach to the Patient in Critical State Following Immunotherapy and/or Stem Cell Transplantation: Guideline for the On-Call Physician

  2019cites this paper
• Long Non-coding RNAs in Myeloid Malignancies

  2019cites this paper
• Exosome-carried microRNA-based signature as a cellular trigger for the evolution of chronic lymphocytic leukemia into Richter syndrome

  2018cites this paper
• From proteomics to discovery of first-in-class ST2 inhibitors active in vivo.

  2018cites this paper
• The search for drug-targetable diagnostic, prognostic and predictive biomarkers in chronic graft-versus-host disease

  2018cites this paper
• Genetically enhanced T lymphocytes and the intensive care unit

  2018cites this paper
• Chimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia

  2018cites this paper
• The new era of nanotechnology, an alternative to change cancer treatment

  2017cites this paper
• Protein dysregulation in graft versus host disease

  2017cites this paper
• The new era of nanotechnology, an alternative to change cancer treatment

  2017cites this paper
• Identification and assessment of molecular biomarkers in haematopoietic stem cell transplantation

  2016cites this paper
• Proceedings from the 1st Insights in Hematology Symposium, Cluj-Napoca, Romania March 11-12, 2016

  2016cites this paper
• Haploidentical Donors: Can Faster Transplantation Be Life-Saving for Patients with Advanced Disease?

  2016cites this paper